Clinical Trial Update: ProA Study: ProActive Management Model in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated by Apalutamide

View source ↗

Summary

Clinical trial update for the ProA Study evaluating an active management model in metastatic hormone-sensitive prostate cancer treated with apalutamide; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ERLEADA (apalutamide)

Snippet

Sponsor: Yonghong Li | Conditions: Prostate Cancer (Adenocarcinoma) | Status: ENROLLING_BY_INVITATION